New drug tested in healthy seniors – no cure, just safety check
NCT ID NCT06699628
First seen Feb 05, 2026 · Last updated May 24, 2026 · Updated 18 times
Summary
This early-stage study tested a single dose of the drug IRL757 in 12 healthy volunteers aged 65 to 89. The goal was to see how the drug moves through the body and whether it is safe. No treatment was given for any disease, so this study does not offer a cure or symptom relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CTC Clinical Trial Consultants AB
Uppsala, Sweden
Conditions
Explore the condition pages connected to this study.